JP2020526337A - 組織足場 - Google Patents

組織足場 Download PDF

Info

Publication number
JP2020526337A
JP2020526337A JP2020501365A JP2020501365A JP2020526337A JP 2020526337 A JP2020526337 A JP 2020526337A JP 2020501365 A JP2020501365 A JP 2020501365A JP 2020501365 A JP2020501365 A JP 2020501365A JP 2020526337 A JP2020526337 A JP 2020526337A
Authority
JP
Japan
Prior art keywords
elastin
cross
linking
scaffold
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2020501365A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020526337A5 (enExample
Inventor
プラサド サワドカー，
プラサド サワドカー，
エレナ ガルシア−ガレタ，
エレナ ガルシア−ガレタ，
Original Assignee
ラフト エンタープライジズ リミテッド
ラフト エンタープライジズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ラフト エンタープライジズ リミテッド, ラフト エンタープライジズ リミテッド filed Critical ラフト エンタープライジズ リミテッド
Publication of JP2020526337A publication Critical patent/JP2020526337A/ja
Publication of JP2020526337A5 publication Critical patent/JP2020526337A5/ja
Priority to JP2023095521A priority Critical patent/JP7693152B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2537/00—Supports and/or coatings for cell culture characterised by physical or chemical treatment
    • C12N2537/10—Cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Laser Surgery Devices (AREA)
  • Surgical Instruments (AREA)
  • Prostheses (AREA)
JP2020501365A 2017-07-14 2018-07-13 組織足場 Ceased JP2020526337A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023095521A JP7693152B2 (ja) 2017-07-14 2023-06-09 組織足場

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1711360.6 2017-07-14
GBGB1711360.6A GB201711360D0 (en) 2017-07-14 2017-07-14 Tissue scaffold
PCT/GB2018/052002 WO2019012295A1 (en) 2017-07-14 2018-07-13 TISSUE SCAFFOLDING

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023095521A Division JP7693152B2 (ja) 2017-07-14 2023-06-09 組織足場

Publications (2)

Publication Number Publication Date
JP2020526337A true JP2020526337A (ja) 2020-08-31
JP2020526337A5 JP2020526337A5 (enExample) 2021-08-19

Family

ID=59713538

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020501365A Ceased JP2020526337A (ja) 2017-07-14 2018-07-13 組織足場
JP2023095521A Active JP7693152B2 (ja) 2017-07-14 2023-06-09 組織足場

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023095521A Active JP7693152B2 (ja) 2017-07-14 2023-06-09 組織足場

Country Status (8)

Country Link
US (2) US11738112B2 (enExample)
EP (2) EP4338764A3 (enExample)
JP (2) JP2020526337A (enExample)
AU (2) AU2018298970B2 (enExample)
CA (1) CA3068926A1 (enExample)
ES (1) ES2948984T3 (enExample)
GB (1) GB201711360D0 (enExample)
WO (1) WO2019012295A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917398A (zh) * 2019-12-09 2020-03-27 沛嘉医疗科技(苏州)有限公司 生物材料的抗氧化方法及生物材料
GB202004902D0 (en) * 2020-04-02 2020-05-20 Univ Oxford Innovation Ltd Methods and products
US12163957B2 (en) * 2020-06-01 2024-12-10 King Abdullah University Of Science And Technology Methods for detecting his-tagged proteins using NTA probes and polyacrylamide gel electrophoresis
CN114767930B (zh) * 2022-04-11 2023-09-22 山东大学齐鲁医院 一种3d纳米纤维海绵体、制备方法及在脊髓损伤修复领域的应用
JP2025005175A (ja) 2023-06-27 2025-01-16 日亜化学工業株式会社 酸化物蛍光体、及びそれを用いた発光装置

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004087232A1 (ja) * 2003-03-31 2004-10-14 Teijin Limited エラスチン成形体およびその製造法
US20080107708A1 (en) * 2006-09-29 2008-05-08 Ng Martin K C Tropoelastin-based protoelastin biomaterials
JP2008291258A (ja) * 2001-05-30 2008-12-04 Keiichi Miyamoto 水溶性エラスチンの架橋剤
JP2010148922A (ja) * 1999-06-10 2010-07-08 Fusion Medical Technologies Inc 血液活性組成物ならびにそれらの製造および使用のための方法
WO2010110067A1 (ja) * 2009-03-27 2010-09-30 株式会社マルハニチロ食品 エラスチン及びコラーゲンを用いた架橋物及びその用途
US20160143726A1 (en) * 2014-11-26 2016-05-26 Integra Lifesciences Corporation Process for Preparing Tissue Regeneration Matrix

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598423B1 (fr) * 1985-03-01 1989-03-17 Inst Nat Sante Rech Med Produit a base d'elastine, procede pour sa preparation et ses applications biologiques, en particulier en tant que biomateriaux et supports artificiels
US5989244A (en) * 1994-11-15 1999-11-23 Gregory; Kenton W. Method of use of a sheet of elastin or elastin-based material
US6638308B2 (en) 1997-10-10 2003-10-28 John D. Corbitt, Jr. Bioabsorbable breast implant
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
JP4030881B2 (ja) 2003-01-08 2008-01-09 ペンタックス株式会社 相対回動環状二部材のバヨネット構造
WO2006046626A1 (ja) 2004-10-29 2006-05-04 Kyushu Institute Of Technology 水溶性エラスチンとその製造方法及びそれを含む食品と医薬
US20070104692A1 (en) 2005-11-07 2007-05-10 Quijano Rodolfo C Breast tissue regeneration
DE102006029605A1 (de) 2006-06-26 2007-12-27 Lazar, Harald, Dr. Brustimplantat
ATE529070T1 (de) 2006-07-31 2011-11-15 Organogenesis Inc Mastopexie- und brustrekonstruktionsprothesen
SG174922A1 (en) 2009-03-27 2011-11-28 Ethicon Inc Medical devices with galvanic particulates
DK2550027T4 (da) 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
US20140005784A1 (en) 2012-06-29 2014-01-02 Allergan, Inc. Textured prosthesis with reduced capsular contracture response
US9433489B2 (en) 2013-03-12 2016-09-06 Soft Tissue Regeneration, Inc. Absorbable synthetic braided matrix for breast reconstruction and hernia repair
JP6143163B2 (ja) 2013-03-22 2017-06-07 国立大学法人三重大学 弾性組織様構造体の製造方法
US20180296313A1 (en) 2015-09-23 2018-10-18 Novus Scientific Ab Three-dimensional medical implant for regeneration of soft tissue
IL281898B2 (en) 2018-10-03 2024-09-01 Estab Labs S A Scaffolding for implantable medical devices and methods of use thereof
DK4126088T3 (da) 2020-03-22 2025-10-20 Collplant Ltd Collagenbaserede formuleringer, der kan anvendes som bløde vævsfyldstoffer og/eller implantater

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010148922A (ja) * 1999-06-10 2010-07-08 Fusion Medical Technologies Inc 血液活性組成物ならびにそれらの製造および使用のための方法
JP2008291258A (ja) * 2001-05-30 2008-12-04 Keiichi Miyamoto 水溶性エラスチンの架橋剤
WO2004087232A1 (ja) * 2003-03-31 2004-10-14 Teijin Limited エラスチン成形体およびその製造法
US20080107708A1 (en) * 2006-09-29 2008-05-08 Ng Martin K C Tropoelastin-based protoelastin biomaterials
WO2010110067A1 (ja) * 2009-03-27 2010-09-30 株式会社マルハニチロ食品 エラスチン及びコラーゲンを用いた架橋物及びその用途
US20160143726A1 (en) * 2014-11-26 2016-05-26 Integra Lifesciences Corporation Process for Preparing Tissue Regeneration Matrix

Also Published As

Publication number Publication date
EP4338764A2 (en) 2024-03-20
US20240165299A1 (en) 2024-05-23
JP7693152B2 (ja) 2025-06-17
GB201711360D0 (en) 2017-08-30
AU2018298970B2 (en) 2024-07-04
AU2018298970A1 (en) 2020-01-30
WO2019012295A1 (en) 2019-01-17
ES2948984T3 (es) 2023-09-22
JP2023105244A (ja) 2023-07-28
AU2024220141A1 (en) 2025-01-30
EP3651817A1 (en) 2020-05-20
EP3651817B1 (en) 2023-05-03
US11738112B2 (en) 2023-08-29
EP4338764A3 (en) 2024-06-05
CA3068926A1 (en) 2019-01-17
US20200164104A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
JP7693152B2 (ja) 組織足場
Majima et al. Alginate and chitosan polyion complex hybrid fibers for scaffolds in ligament and tendon tissue engineering
US10736989B2 (en) Methods and compositions for stabilizing the myocardium
CA2701858C (en) Method for preparing porous scaffold for tissue engineering, cell culture and cell delivery
EP1803472B1 (en) Biomaterial for suture
Dong et al. Demineralized and decellularized bone extracellular matrix-incorporated electrospun nanofibrous scaffold for bone regeneration
US11998658B2 (en) Injectable porous hydrogels
CA2863967A1 (en) Liquefaction of bone matrix
JP2007277579A (ja) ポリアニオン性多糖類と疎水性生物吸収ポリマーを含む組成物
US20100190704A1 (en) Structure comprising chitosan and collagen
CA2896587C (en) Compositions comprising citrate and applications thereof
WO2014133027A1 (ja) ハイドロゲル
Li et al. Gelatin methacryloyl hydrogels functionalized with endothelin-1 for angiogenesis and full-thickness wound healing
CN1674946A (zh) 来自角蛋白的矫形材料
US11147899B2 (en) Flap for de-novo tissue regeneration
US20140341874A1 (en) Dextran-based tissuelette containing platelet-rich plasma lysate for cartilage repair
JPH10501706A (ja) 細胞−ゲル
Liu et al. Angiogenesis potential of bladder acellular matrix hydrogel by compounding endothelial cells
Aili et al. Evaluation of a hydroxyapatite-crosslinked fish gelatin membranes
Wessels et al. Enhanced stabilization of collagen-based dermal regeneration scaffolds through the combination of physical and chemical crosslinking
Wang et al. Chitosan/Gelatin/Carrageenan as a Composite Scaffolding Material for Cartilage Tissue Engineering
Chen et al. Chondroitin Sulphate and Gas Foaming Concurrently Improve Articular Cartilage Regeneration in Electrospun Poly (L-lactide-co-ε-caprolactone)/Silk Fibroin Based Scaffolds
JP7414284B2 (ja) コラーゲン固形物、コラーゲン固形物の製造方法、生体材料、および、生体外材料
WO2023170316A1 (en) Hydrogel suitable to produce artificial tissues
CN119746171A (zh) 一种用于损伤修复的水凝胶-微球复合支架材料

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210712

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210712

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220603

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220902

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230609

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230710

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230803

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230830

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20231215